Disparities in Breast Cancer Screening for Disadvantaged Americans

This white paper evaluates disparities in breast cancer screening rates among disadvantaged populations in the United States, focusing on trends from 2017 to 2023. It highlights the critical role of breast cancer screening in early diagnosis and treatment, which can significantly improve outcomes and reduce mortality rates. The study utilizes data from various insurance types, including traditional Medicare Fee-for-Service, Medicare Advantage, commercial, and Medicaid, to analyze screening rates among women aged 50 to 74. The findings indicate that women with Medicaid consistently have the lowest screening rates, ranging from 40% to 55%, influenced by factors such as income, education, and English proficiency. The paper emphasizes the need to address barriers to screening for these populations to enhance health equity and improve overall health outcomes. It also references the Healthcare Effectiveness Data and Information Set (HEDIS) as a key measure in evaluating screening performance and the importance of preventative care in combating chronic diseases like breast cancer.